Fintel reports that on October 3, 2024, Oppenheimer initiated coverage of Dianthus Therapeutics (NasdaqCM:DNTH) with a Outperform recommendation.
Fintel reports that on October 3, 2024, Compass Point initiated coverage of Two Harbors Investment - Preferred Stock (NYSE:TWO.PRA) with a Buy recommendation.
Zacks Investment Research has recently initiated coverage of Rave Restaurant Group, Inc. RAVE, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed outlook for the company, which has bee
Fintel reports that on October 2, 2024, Evercore ISI Group initiated coverage of S&P Global (XTRA:MHL) with a Outperform recommendation.
Fintel reports that on October 2, 2024, Evercore ISI Group initiated coverage of S&P Global (WBAG:SPGI) with a Outperform recommendation.
Fintel reports that on October 2, 2024, Evercore ISI Group initiated coverage of Moody's (WBAG:MOCO) with a Outperform recommendation.
Fintel reports that on October 1, 2024, Raymond James initiated coverage of LCI Industries (NYSE:LCII) with a Market Perform recommendation.
Fintel reports that on October 1, 2024, Wedbush initiated coverage of Perspective Therapeutics (NYSEAM:CATX) with a Outperform recommendation.
Fintel reports that on October 1, 2024, Oppenheimer initiated coverage of Pagaya Technologies (NasdaqCM:PGY) with a Outperform recommendation.
Fintel reports that on October 1, 2024, HC Wainwright & Co. initiated coverage of Neumora Therapeutics (NasdaqGS:NMRA) with a Buy recommendation.
Fintel reports that on October 1, 2024, Stephens & Co. initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with a Overweight recommendation.
Fintel reports that on October 1, 2024, Exane BNP Paribas initiated coverage of NextEra Energy Partners, LP - Limited Partnership (NYSE:NEP) with a Underperform recommendation.
Fintel reports that on September 30, 2024, Ladenburg Thalmann initiated coverage of Crescent Capital BDC (NasdaqGM:CCAP) with a Buy recommendation.
Fintel reports that on September 30, 2024, CICC initiated coverage of ZKH Group Limited - Depositary Receipt () (NYSE:ZKH) with a Outperform recommendation.
Fintel reports that on September 30, 2024, William Blair initiated coverage of Tenax Therapeutics (NasdaqCM:TENX) with a Outperform recommendation.
Fintel reports that on September 30, 2024, Goldman Sachs initiated coverage of Celldex Therapeutics (NasdaqCM:CLDX) with a Neutral recommendation.
Fintel reports that on September 30, 2024, HC Wainwright & Co. initiated coverage of BioLife Solutions (NasdaqCM:BLFS) with a Buy recommendation.
Fintel reports that on September 30, 2024, B of A Securities initiated coverage of Navient Corporation - Preferred Security (NasdaqGS:JSM) with a Neutral recommendation.
Fintel reports that on September 27, 2024, Raymond James initiated coverage of LENZ Therapeutics (NasdaqGS:LENZ) with a Outperform recommendation.
Fintel reports that on September 27, 2024, Jones Trading initiated coverage of KalVista Pharmaceuticals (NasdaqGM:KALV) with a Buy recommendation.
Fintel reports that on September 27, 2024, Citigroup initiated coverage of USA Compression Partners, LP - Limited Partnership (NYSE:USAC) with a Neutral recommendation.
Fintel reports that on September 27, 2024, Raymond James initiated coverage of MercadoLibre (XTRA:MLB1) with a Outperform recommendation.